# US 6,297,007 B1 · Method for isolation of biosynthesis genes for bioactive molecules > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 6,297,007 B1 - Document ID: US6297007B1 - Status: Granted - Kind: B1 - Application number: 08/861,774 - Filed: 1997-05-22 - Granted: 2001-10-02 - Earliest claimed: 1997-05-22 - Assignees: Terragen Diversity, Inc. - Inventors: Barbara Waters; Vivian Miao; Yap Wai Ho; Seow Kah Tong - Web page: https://patentgrep.com/patent/US6297007B1 ## CPC - C12Q 1/6895: for plants, fungi or algae - C12Q 1/689: for bacteria - C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES ## Abstract Degenerate primers which hybridize with various classes of antibiotic biosynthesis genes were used to amplify fragments of DNA from soil and lichen extracts. Cloning and sequencing of the amplified products showed that these products included a variety of novel and previously uncharacterized antibiotic biosynthesis gene sequences, the products of which have the potential to be active as antibiotics, immunosuppressors, antitumor agents, etc. Thus, antibiotic biosynthesis genes can be recovered from soil or lichens by a combining a sample with a pair of amplification primers under conditions suitable for polymerase chain reaction amplification, wherein the primer set is a degenerate primer set selected to hybridize with conserved regions of known antibiotic biosynthetic pathway genes, for example Type I and Type II polyketide synthase genes, isopenicillin N synthase genes, and peptide synthetase genes; cycling the combined sample through a plurality of amplification cycles to amplify DNA complementary to the primer set; and isolating the amplified DNA. ## Claims ### Claim 1 A method for recovery of DNA comprising a nucleotide sequence of a portion of a gene that encodes a protein that is involved in antibiotic synthesis, from humic materials or lichen, comprising the steps of: (a) combining a DNA sample derived from humic material or lichen with a set of oligonucleotide primers in a reaction mixture which comprises a DNA polymerase and deoxynucleotide triphosphates, wherein the primers are capable of hybridizing to nucleotide sequences that encode conserved regions of a protein, the protein being involved in antibiotic synthesis; (b) amplifying the DNA flanked by the nucleotide sequences that encode conserved regions of the protein in the reaction mixture by polymerase chain reaction; and (c) isolating the amplified DNA from the reaction mixture. ### Claim 2 (depends on 1) The method according to claim 1, wherein the set of olilonucleotide primers comprises oligonucleotide primers that hybridize to nucleotide sequences encoding a protein that is involved in polyketide synthesis. ### Claim 3 (depends on 2) The method according to claim 2, wherein the set of oligonucleotide primers comprises oligonucleotide primers that consist essentially of the nucleotide sequence set forth in SEQ ID NO:1, oligonucleotide primers that consist essentially of the nucleotide sequence set forth in SEQ ID NO:2, or both. ### Claim 4 (depends on 2) The method according to claim 2, wherein the set of oligonucleotide primers comprises oligonucleotide primers that consist essentially of the nucleotide sequence set forth in SEQ ID NO:3, oligonucleotide primers that consist essentially of the nucleotide sequence set forth in SEQ ID NO: 4, or both. ### Claim 5 (depends on 2) The method according to claim 2, wherein the set of oligonucleotide primers comprises oligonucleotide primers that consist essentially of the nucleotide sequence set forth in SEQ ID NO: 5, oligonucleotide primers that consist essentially of the nucleotide sequence set forth in SEQ ID NO: 6, or both. ### Claim 6 (depends on 2) The method according to claim 2, wherein the set of oligonucleotide primers comprises oligonucleotide primers that consist essentially of the nucleotide sequence set forth in SEQ ID NO: 11, oligonucleotide primers that consist essentially of the nucleotide sequence set forth in SEQ ID NO: 12, or both. ### Claim 7 (depends on 1) The method according to claim 1, wherein the set of oligonucleotide primers comprises oligonucleotide primers that hybridize to nucleotide sequences encoding an isopenicillin N synthase gene. ### Claim 8 (depends on 7) The method according to claim 7, wherein the set of oligonucleotide primers comprises oligonucleotide primers that consist essentially of the nucleotide sequence set forth in SEQ ID NO:7, oligonucleotide primers that consist essentially of the nucleotide sequence set forth in SEQ ID NO:8. or both. ### Claim 9 (depends on 1) The method according to claim 1, wherein the set of oligonucleotide primers comprises oligonucleotide primers that hybridize to nucleotide sequences encoding a polyketide synthase gene. ### Claim 10 (depends on 9) The method according to claim 9, wherein the set of oligonucleotide primers comprises oligonucleotide primers that consist essentially of the nucleotide sequence set forth in SEQ ID NO:9, oligonucleotide primers that consisting essentially of the nucleotide sequence set forth in SEQ ID NO: 10, or both. ### Claim 11 (depends on 1) The method according to claim 1, wherein the sample comprises DNA extracted from a soil sample. ### Claim 12 (depends on 1) The method according to claim 1, wherein the sample is a lichen-derived sample. ### Claim 13 (depends on 1) The method according to claim 1, further comprising the steps of cloning the amplified DNA into a host organism, and isolating the cloned DNA. ### Claim 14 (depends on 13) The method according to claim 13, wherein the host organism is E. coli. ### Claim 15 An oligonucleotide primer consisting essentially of the sequence as defined in SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7 or SEQ ID NO:8. ### Claim 16 A composition comprising two oligonucleotide primers, said oligonucleotide primers each consisting essentially of the sequence as defined in (i) SEQ ID NO: 1 or SEQ ID NO:2; (ii) SEQ ID NO:3 or SEQ ID NO:4; (iii) SEQ ID NO:5 or SEQ ID NO:6; or (iv) SEQ ID NO:7 or SEQ ID NO:8.